Agency Information Collection Activities: Proposed Collection; Comment Request, 37227-37228 [2024-09812]
Download as PDF
Federal Register / Vol. 89, No. 88 / Monday, May 6, 2024 / Notices
request for comments. The comment
seems to be unsolicited bulk email.
Obtaining Copies: Requesters may
obtain a copy of the information
collection documents from the GSA
Regulatory Secretariat Division, by
calling 202–501–4755 or emailing
GSARegSec@gsa.gov. Please cite OMB
Control No. 9000–0188, Combating
Trafficking in Persons.
SUPPLEMENTARY INFORMATION:
Janet Fry,
Director, Federal Acquisition Policy Division,
Office of Governmentwide Acquisition Policy,
Office of Acquisition Policy, Office of
Governmentwide Policy.
[FR Doc. 2024–09781 Filed 5–3–24; 8:45 am]
BILLING CODE 6820–EP–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Public Webinar: National Public Health
Strategy for the Prevention and
Control of Vector-Borne Diseases in
People
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of public webinar.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), within
the Department of Health and Human
Services (HHS), is announcing a closed
meeting and public webinar to share
information on the National Public
Health Strategy for the Prevention and
Control of Vector-Borne Diseases in
People (VBD National Strategy). The full
meeting will be by invitation only to
ensure representation and inclusion of
researchers, clinicians, public health
officials, vector control officials, and
patient advocates. However, the public
is invited to listen virtually to the
opening and closing sessions
(attendance via livestream is unlimited).
DATES: The public webinar will be held
on May 23, 2024, from 10:00 a.m. to
11:00 a.m. and 3:00 p.m. to 4:00 p.m.,
Eastern time.
ADDRESSES: The public webinar will be
available by livestream. To access the
meeting visit this page on the day of the
event: https://www.hhs.gov/live/
index.html.
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
Background: Leaders from CDC’s
Division of Vector-Borne Disease
(DVBD) will host an in-person and
online meeting about the National
Public Health Strategy for the
Prevention and Control of Vector-Borne
Diseases in People (VBD National
Strategy). The VBD National Strategy
was developed by the Department of
Health and Human Services in response
to congressional direction in the Kay
Hagan Tick Act, passed as part of the
Further Consolidated Appropriations
Act, 2020 (Pub. L. 116–94). The primary
purpose of the meeting is to increase
awareness of the VBD National Strategy
and inform future implementation
efforts.
The public is invited to attend the
opening and closing sessions of the
meeting. In the opening session,
speakers will describe the VBD National
Strategy and federal agency
representatives will present 2023
success stories. After the opening
session, invited participants will
participate in a set of interactive
activities to collect individual opinions
from a range of invited meeting
participants with vector-borne disease
experience. The public will be invited
to a closing session at which time a
summary of the interactive sessions will
be shared.
This meeting follows previous public
engagement activities, including the two
Requests for Information previously
published in the Federal Register on
April 27, 2021, (86 FR 23391) and
November 21, 2022, (87 FR 70836).
Additional information and public
comments can be found on
www.regulations.gov in dockets HHS–
OASH–2021–0012 and HHS–OASH–
2022–0019.
Public Webinar: The opening and
closing sessions will be open to the
public to an unlimited number of
viewers via livestream.
Noah Aleshire,
Chief Regulatory Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2024–09774 Filed 5–3–24; 8:45 am]
BILLING CODE 4163–18–P
Sue
Visser, DrPH, MS, Deputy Director for
Policy and Extramural Program; Fort
Collins, CO (Offices and Laboratories),
3156 Rampart Road, Fort Collins, CO
80521; Telephone: 404–498–3008;
Email: vbdstrategy@cdc.gov.
FOR FURTHER INFORMATION CONTACT:
VerDate Sep<11>2014
18:02 May 03, 2024
Jkt 262001
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
37227
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–10636, CMS–
10874, and CMS–319]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), Federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
July 5, 2024.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number: ll, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
SUMMARY:
E:\FR\FM\06MYN1.SGM
06MYN1
37228
Federal Register / Vol. 89, No. 88 / Monday, May 6, 2024 / Notices
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, please access the CMS PRA
website by copying and pasting the
following web address into your web
browser: https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing
FOR FURTHER INFORMATION CONTACT:
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
ddrumheller on DSK120RN23PROD with NOTICES1
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS—10636 Triennial Network
Adequacy Review for Medicare
Advantage Organizations and 1876
Cost Plans
CMS—10874 Part D Drug Management
Program
CMS—319 State Medicaid Eligibility
Quality Control Sample Selection
Lists and Supporting Regulations
Under the PRA (44 U.S.C. 3501–
3520), Federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires Federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collection
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Triennial
Network Adequacy Review for Medicare
Advantage Organizations and 1876 Cost
Plans; Use: CMS regulations at 42 CFR
417.414, 417.416, 422.112(a)(1)(i), and
422.114(a)(3)(ii) require that all
Medicare Advantage organizations
(MAOs) offering coordinated care plans,
network-based private fee-for-service
(PFFS) plans, and as well as section
VerDate Sep<11>2014
18:02 May 03, 2024
Jkt 262001
1876 cost organizations, maintain a
network of appropriate providers that is
sufficient to provide adequate access to
covered services to meet the needs of
the population served. To enforce this
requirement, CMS regulations at
§ 422.116 outline network adequacy
criteria which set forth the minimum
number of providers and maximum
travel time and distance from enrollees
to providers, for required provider
specialty types in each county in the
United States and its territories.
Organizations must be in compliance
with the current CMS network adequacy
criteria guidance, which is updated and
published annually on CMS’s website.
This collection of information is
essential to appropriate and timely
compliance monitoring by CMS, in
order to ensure that all active contracts
offering network-based plans maintain
an adequate network; Form Number:
CMS–10636 (OMB control number:
0938–1346); Frequency: Yearly; Affected
Public: Private sector; Number of
Respondents: 502; Number of
Responses: 2,753; Total Annual Hours:
27,470. (For policy questions regarding
this collection contact Jackie Ford at
410–786–7767.)
2. Type of Information Collection
Request: New collection (Request for a
new OMB control number); Title of
Information Collection: Part D Drug
Management Program (DMP); Use:
Section 1860D–4(c)(5)(A) of the Social
Security Act requires that Part D
sponsors have a DMP for beneficiaries at
risk of abuse or misuse of frequently
abused drugs (FADs). The information
in this collection of information request
is necessary for sponsor conformance
with DMP requirements at § 423.153(f),
including communicating with
prescribers and pharmacies, informing
beneficiaries that they have been
identified as a PARB or ARB, and
informing beneficiaries and CMS
whether a beneficiary’s access to FADs
will be restricted to a selected prescriber
and/or network pharmacy(ies) and/or
through a beneficiary-specific point-ofsale claim edit. Part D sponsors will use
the standardized and model documents
to communicate with providers,
enrollees, and other sponsors.
Specifically, Part D sponsors may use
the Model Part D Drug Management
Program Prescriber Inquiry Letter to
inform providers that their patient’s
pattern of use or history of use of FADs
is potentially unsafe and has prompted
a case management review under the
plan’s DMP. Part D sponsors must use
the standardized Initial Notice and
Second Notice, or Alternate Second
Notice, to inform enrollees, following
PO 00000
Frm 00069
Fmt 4703
Sfmt 9990
identification by CMS’s OMS and
subsequent case management, whether
the beneficiaries have been identified as
being potentially at risk or at risk for
abuse or misuse of FADs. Part D
sponsors may use the Model Part D Drug
Management Program Sponsor
Information Transfer Memorandum to
communicate to a gaining sponsor the
enrollee’s history of misuse or abuse of
FADs; Form Number: CMS–10874 (OMB
control number: 0938–1465); Frequency:
Yearly and once; Affected Public:
Private sector; Number of Respondents:
319; Number of Responses: 62,248;
Total Annual Hours: 152,585. (For
policy questions regarding this
collection contact Valerie Yingling at
667–290–8657.)
3. Type of Information Collection
Request: Reinstatement with change to
the previously approved information
collection: Title of Information
Collection: State Medicaid Eligibility
Quality Control Sample Selection Lists
and Supporting Regulations; Use: Title
XIX and Title XXI State agencies are
required to submit the MEQC pilot
planning document in accordance with
§ 431.814(b), and the MEQC case level
and CAP reports based on pilot findings
in accordance with §§ 431.816 and
431.820, respectively. The primary users
of this information are State Medicaid
(and where applicable CHIP) agencies
and CMS. State agencies are expected to
use the information collected for
continuous quality improvement
purposes. They will identify patterns of
error in their eligibility processing
operations and systems and take
corrective actions to address issues and
improve the eligibility determination
process. CMS will use the data collected
to identify and help those States that are
most in need of technical assistance.
CMS will also use the data set to
identify potential weaknesses in Federal
regulations. It will propose regulatory
modifications designed to ensure that
there are more effective quality controls
in the eligibility determination process.;
Form Number: CMS–319 (OMB control
number: 0938–0147); Frequency:
Occasionally; Affected Public: State,
Local, or Tribal Governments; Number
of Respondents: 35; Number of
Responses: 647; Total Annual Hours:
9,840. (For policy questions regarding
this collection contact Camiel Rowe at
410–786–0069.)
William N. Parham, III,
Director, Division of Information Collections
and Regulatory Impacts, Office of Strategic
Operations and Regulatory Affairs.
[FR Doc. 2024–09812 Filed 5–3–24; 8:45 am]
BILLING CODE 4120–01–P
E:\FR\FM\06MYN1.SGM
06MYN1
Agencies
[Federal Register Volume 89, Number 88 (Monday, May 6, 2024)]
[Notices]
[Pages 37227-37228]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-09812]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifiers: CMS-10636, CMS-10874, and CMS-319]
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Centers for Medicare & Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is
announcing an opportunity for the public to comment on CMS' intention
to collect information from the public. Under the Paperwork Reduction
Act of 1995 (PRA), Federal agencies are required to publish notice in
the Federal Register concerning each proposed collection of information
(including each proposed extension or reinstatement of an existing
collection of information) and to allow 60 days for public comment on
the proposed action. Interested persons are invited to send comments
regarding our burden estimates or any other aspect of this collection
of information, including the necessity and utility of the proposed
information collection for the proper performance of the agency's
functions, the accuracy of the estimated burden, ways to enhance the
quality, utility, and clarity of the information to be collected, and
the use of automated collection techniques or other forms of
information technology to minimize the information collection burden.
DATES: Comments must be received by July 5, 2024.
ADDRESSES: When commenting, please reference the document identifier or
OMB control number. To be assured consideration, comments and
recommendations must be submitted in any one of the following ways:
1. Electronically. You may send your comments electronically to
https://www.regulations.gov. Follow the instructions for ``Comment or
Submission'' or ``More Search Options'' to find the information
collection document(s) that are accepting comments.
2. By regular mail. You may mail written comments to the following
address: CMS, Office of Strategic Operations and Regulatory Affairs,
Division of Regulations Development, Attention: Document Identifier/OMB
Control Number: __, Room C4-26-05, 7500 Security Boulevard, Baltimore,
Maryland 21244-1850.
[[Page 37228]]
To obtain copies of a supporting statement and any related forms
for the proposed collection(s) summarized in this notice, please access
the CMS PRA website by copying and pasting the following web address
into your web browser: https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing
FOR FURTHER INFORMATION CONTACT: William N. Parham at (410) 786-4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the use and burden associated
with the following information collections. More detailed information
can be found in each collection's supporting statement and associated
materials (see ADDRESSES).
CMS--10636 Triennial Network Adequacy Review for Medicare Advantage
Organizations and 1876 Cost Plans
CMS--10874 Part D Drug Management Program
CMS--319 State Medicaid Eligibility Quality Control Sample Selection
Lists and Supporting Regulations
Under the PRA (44 U.S.C. 3501-3520), Federal agencies must obtain
approval from the Office of Management and Budget (OMB) for each
collection of information they conduct or sponsor. The term
``collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA requires Federal agencies
to publish a 60-day notice in the Federal Register concerning each
proposed collection of information, including each proposed extension
or reinstatement of an existing collection of information, before
submitting the collection to OMB for approval. To comply with this
requirement, CMS is publishing this notice.
Information Collection
1. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Triennial Network
Adequacy Review for Medicare Advantage Organizations and 1876 Cost
Plans; Use: CMS regulations at 42 CFR 417.414, 417.416,
422.112(a)(1)(i), and 422.114(a)(3)(ii) require that all Medicare
Advantage organizations (MAOs) offering coordinated care plans,
network-based private fee-for-service (PFFS) plans, and as well as
section 1876 cost organizations, maintain a network of appropriate
providers that is sufficient to provide adequate access to covered
services to meet the needs of the population served. To enforce this
requirement, CMS regulations at Sec. 422.116 outline network adequacy
criteria which set forth the minimum number of providers and maximum
travel time and distance from enrollees to providers, for required
provider specialty types in each county in the United States and its
territories. Organizations must be in compliance with the current CMS
network adequacy criteria guidance, which is updated and published
annually on CMS's website. This collection of information is essential
to appropriate and timely compliance monitoring by CMS, in order to
ensure that all active contracts offering network-based plans maintain
an adequate network; Form Number: CMS-10636 (OMB control number: 0938-
1346); Frequency: Yearly; Affected Public: Private sector; Number of
Respondents: 502; Number of Responses: 2,753; Total Annual Hours:
27,470. (For policy questions regarding this collection contact Jackie
Ford at 410-786-7767.)
2. Type of Information Collection Request: New collection (Request
for a new OMB control number); Title of Information Collection: Part D
Drug Management Program (DMP); Use: Section 1860D-4(c)(5)(A) of the
Social Security Act requires that Part D sponsors have a DMP for
beneficiaries at risk of abuse or misuse of frequently abused drugs
(FADs). The information in this collection of information request is
necessary for sponsor conformance with DMP requirements at Sec.
423.153(f), including communicating with prescribers and pharmacies,
informing beneficiaries that they have been identified as a PARB or
ARB, and informing beneficiaries and CMS whether a beneficiary's access
to FADs will be restricted to a selected prescriber and/or network
pharmacy(ies) and/or through a beneficiary-specific point-of-sale claim
edit. Part D sponsors will use the standardized and model documents to
communicate with providers, enrollees, and other sponsors.
Specifically, Part D sponsors may use the Model Part D Drug Management
Program Prescriber Inquiry Letter to inform providers that their
patient's pattern of use or history of use of FADs is potentially
unsafe and has prompted a case management review under the plan's DMP.
Part D sponsors must use the standardized Initial Notice and Second
Notice, or Alternate Second Notice, to inform enrollees, following
identification by CMS's OMS and subsequent case management, whether the
beneficiaries have been identified as being potentially at risk or at
risk for abuse or misuse of FADs. Part D sponsors may use the Model
Part D Drug Management Program Sponsor Information Transfer Memorandum
to communicate to a gaining sponsor the enrollee's history of misuse or
abuse of FADs; Form Number: CMS-10874 (OMB control number: 0938-1465);
Frequency: Yearly and once; Affected Public: Private sector; Number of
Respondents: 319; Number of Responses: 62,248; Total Annual Hours:
152,585. (For policy questions regarding this collection contact
Valerie Yingling at 667-290-8657.)
3. Type of Information Collection Request: Reinstatement with
change to the previously approved information collection: Title of
Information Collection: State Medicaid Eligibility Quality Control
Sample Selection Lists and Supporting Regulations; Use: Title XIX and
Title XXI State agencies are required to submit the MEQC pilot planning
document in accordance with Sec. 431.814(b), and the MEQC case level
and CAP reports based on pilot findings in accordance with Sec. Sec.
431.816 and 431.820, respectively. The primary users of this
information are State Medicaid (and where applicable CHIP) agencies and
CMS. State agencies are expected to use the information collected for
continuous quality improvement purposes. They will identify patterns of
error in their eligibility processing operations and systems and take
corrective actions to address issues and improve the eligibility
determination process. CMS will use the data collected to identify and
help those States that are most in need of technical assistance. CMS
will also use the data set to identify potential weaknesses in Federal
regulations. It will propose regulatory modifications designed to
ensure that there are more effective quality controls in the
eligibility determination process.; Form Number: CMS-319 (OMB control
number: 0938-0147); Frequency: Occasionally; Affected Public: State,
Local, or Tribal Governments; Number of Respondents: 35; Number of
Responses: 647; Total Annual Hours: 9,840. (For policy questions
regarding this collection contact Camiel Rowe at 410-786-0069.)
William N. Parham, III,
Director, Division of Information Collections and Regulatory Impacts,
Office of Strategic Operations and Regulatory Affairs.
[FR Doc. 2024-09812 Filed 5-3-24; 8:45 am]
BILLING CODE 4120-01-P